Cargando…

Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain

INTRODUCTION: In December 2020, vaccination against SARS-CoV-2 started in Spain. Until March 2022, 91.1% of the target population was vaccinated. The objective of the study is to describe the characteristics of patients with SARS-CoV-2 infection, the risk of serious outcomes and their vaccination st...

Descripción completa

Detalles Bibliográficos
Autores principales: Giesen, Christine, Saa-Requejo, Carmen, Lopez-Carrillo, Inmaculada, Ortega-Torres, Angelica, García-Fernández, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683835/
http://dx.doi.org/10.1016/j.vacune.2022.10.013
_version_ 1784835140191518720
author Giesen, Christine
Saa-Requejo, Carmen
Lopez-Carrillo, Inmaculada
Ortega-Torres, Angelica
García-Fernández, Cristina
author_facet Giesen, Christine
Saa-Requejo, Carmen
Lopez-Carrillo, Inmaculada
Ortega-Torres, Angelica
García-Fernández, Cristina
author_sort Giesen, Christine
collection PubMed
description INTRODUCTION: In December 2020, vaccination against SARS-CoV-2 started in Spain. Until March 2022, 91.1% of the target population was vaccinated. The objective of the study is to describe the characteristics of patients with SARS-CoV-2 infection, the risk of serious outcomes and their vaccination status. MATERIAL AND METHODS: Retrospective longitudinal analytical observational study. Demographic characteristics and outcomes of COVID-19 infections and vaccination history from 01/01/2021–08/10/2021 were collected from electronic medical records and the Unified Vaccination Registry. Data analysis was performed with Excel and Stata 16. RESULTS: 4161 COVID-19 cases were detected; of which 185 (4.5%) had received a complete vaccination schedule. The most affected age group was 80–89 years (34.1%). 1697 patients were hospitalized, of whom 78 (4.6%) had been vaccinated against SARS-CoV-2. No patient admitted to the ICU had a history of vaccination. The mean hospitalization time in unvaccinated patients was 11 days (95% CI -41.54–63.54) compared to 8.5 days (95% CI 7.04–9.96) in vaccinated patients. The relative risk of hospitalization in vaccinated patients compared to unvaccinated patients for the age group 40 to 59 years was 0.29 (95% CI 0.11–0.72) and 0.77 (95% CI 0.67–0). 0.90) for people over 60 years of age. CONCLUSIONS: The risk of hospitalization and death was lower in vaccinated patients compared to unvaccinated patients in the age groups 40–59 and older than 60 years. This finding supports current clinical evidence.
format Online
Article
Text
id pubmed-9683835
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-96838352022-11-25 Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain Giesen, Christine Saa-Requejo, Carmen Lopez-Carrillo, Inmaculada Ortega-Torres, Angelica García-Fernández, Cristina Vacunas (English Edition) Original INTRODUCTION: In December 2020, vaccination against SARS-CoV-2 started in Spain. Until March 2022, 91.1% of the target population was vaccinated. The objective of the study is to describe the characteristics of patients with SARS-CoV-2 infection, the risk of serious outcomes and their vaccination status. MATERIAL AND METHODS: Retrospective longitudinal analytical observational study. Demographic characteristics and outcomes of COVID-19 infections and vaccination history from 01/01/2021–08/10/2021 were collected from electronic medical records and the Unified Vaccination Registry. Data analysis was performed with Excel and Stata 16. RESULTS: 4161 COVID-19 cases were detected; of which 185 (4.5%) had received a complete vaccination schedule. The most affected age group was 80–89 years (34.1%). 1697 patients were hospitalized, of whom 78 (4.6%) had been vaccinated against SARS-CoV-2. No patient admitted to the ICU had a history of vaccination. The mean hospitalization time in unvaccinated patients was 11 days (95% CI -41.54–63.54) compared to 8.5 days (95% CI 7.04–9.96) in vaccinated patients. The relative risk of hospitalization in vaccinated patients compared to unvaccinated patients for the age group 40 to 59 years was 0.29 (95% CI 0.11–0.72) and 0.77 (95% CI 0.67–0). 0.90) for people over 60 years of age. CONCLUSIONS: The risk of hospitalization and death was lower in vaccinated patients compared to unvaccinated patients in the age groups 40–59 and older than 60 years. This finding supports current clinical evidence. Published by Elsevier España, S.L.U. 2022 2022-11-24 /pmc/articles/PMC9683835/ http://dx.doi.org/10.1016/j.vacune.2022.10.013 Text en © 2022 Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original
Giesen, Christine
Saa-Requejo, Carmen
Lopez-Carrillo, Inmaculada
Ortega-Torres, Angelica
García-Fernández, Cristina
Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title_full Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title_fullStr Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title_full_unstemmed Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title_short Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain
title_sort risks of adverse outcomes in covid-19 patients and vaccination status in a secondary hospital in spain
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683835/
http://dx.doi.org/10.1016/j.vacune.2022.10.013
work_keys_str_mv AT giesenchristine risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain
AT saarequejocarmen risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain
AT lopezcarrilloinmaculada risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain
AT ortegatorresangelica risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain
AT garciafernandezcristina risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain
AT risksofadverseoutcomesincovid19patientsandvaccinationstatusinasecondaryhospitalinspain